Germany's cannabis act: a catalyst for European drug policy reform?

Manthey J, Rehm J, Verthein U

Open source

DOI
10.1016/j.lanepe.2024.100929
Published
2024 Jul
Container
The Lancet regional health. Europe
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lanepe.2024.100929,
  title = {Germany's cannabis act: a catalyst for European drug policy reform?},
  author = {Manthey J and Rehm J and Verthein U},
  year = {2024},
  journal = {The Lancet regional health. Europe},
  doi = {10.1016/j.lanepe.2024.100929},
  url = {https://doi.org/10.1016/j.lanepe.2024.100929}
}

RIS

TY  - JOUR
TI  - Germany's cannabis act: a catalyst for European drug policy reform?
AU  - Manthey J
AU  - Rehm J
AU  - Verthein U
PY  - 2024
JO  - The Lancet regional health. Europe
DO  - 10.1016/j.lanepe.2024.100929
UR  - https://doi.org/10.1016/j.lanepe.2024.100929
ER  - 

APA

J, M., J, R., & U, V. (2024). Germany's cannabis act: a catalyst for European drug policy reform?. The Lancet regional health. Europe. https://doi.org/10.1016/j.lanepe.2024.100929

Source records